• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Improved intranasal immunization with live-attenuated measles virus after co-inoculation of the lipopeptide MALP-2.

作者信息

Lührmann Anke, Tschernig Thomas, Pabst Reinhard, Niewiesk Stefan

机构信息

Functional and Applied Anatomy, Medical School of Hannover, Hannover, Germany.

出版信息

Vaccine. 2005 Sep 15;23(39):4721-6. doi: 10.1016/j.vaccine.2005.05.009.

DOI:10.1016/j.vaccine.2005.05.009
PMID:15964669
Abstract

The macrophage-activating lipopeptide with a molecular weight of 2kDa (MALP-2) activates antigen presenting cells of human, mouse and rat origin in vitro and in vivo. Here, we demonstrate that MALP-2 induces MIP1alpha and beta, MIP-2, Gro, TNFalpha, IL1alpha and IL6 in cells of cotton rats (Sigmodon hispidus) in vitro. Intranasal inoculation into cotton rats leads to migration of neutrophils and other leucocytes into the lung lumen and lung tissue. After intranasal co-inoculation of MALP-2 with live-attenuated measles vaccine virus, higher titers of neutralizing antibodies are induced but the proliferative T cell response did not increase. Immunization leads to protective immunity in the absence, but not in the presence of passively transferred measles virus (MV) specific antibodies.

摘要

相似文献

1
Improved intranasal immunization with live-attenuated measles virus after co-inoculation of the lipopeptide MALP-2.
Vaccine. 2005 Sep 15;23(39):4721-6. doi: 10.1016/j.vaccine.2005.05.009.
2
Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose.在存在麻疹病毒特异性抗体的情况下,对棉鼠进行成功的粘膜免疫取决于疫苗载体的减毒程度和病毒剂量。
J Gen Virol. 2003 Aug;84(Pt 8):2145-2151. doi: 10.1099/vir.0.19050-0.
3
Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.减毒伤寒沙门氏菌血清型伤寒菌株和福氏志贺氏菌2a菌株经黏膜递送编码麻疹病毒血凝素的DNA疫苗,可在棉鼠体内诱导特异性免疫反应并提供保护。
J Virol. 2003 May;77(9):5209-17. doi: 10.1128/jvi.77.9.5209-5217.2003.
4
The Mycoplasma-derived macrophage-activating 2-kilodalton lipopeptide triggers global immune activation on nasal mucosa-associated lymphoid tissues.支原体来源的巨噬细胞激活2千道尔顿脂肽触发鼻黏膜相关淋巴组织的全身免疫激活。
Infect Immun. 2004 Dec;72(12):6978-86. doi: 10.1128/IAI.72.12.6978-6986.2004.
5
Infection-enhancing lipopeptides do not improve intranasal immunization of cotton rats with a delta-G candidate live-attenuated human respiratory syncytial virus vaccine.感染增强型脂肽不能改善德尔塔-G 候选减毒活人类呼吸道合胞病毒疫苗经鼻腔免疫棉鼠的效果。
Hum Vaccin Immunother. 2013 Dec;9(12):2578-83. doi: 10.4161/hv.26096. Epub 2013 Aug 16.
6
The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant.支原体来源的脂肽MALP-2是一种有效的黏膜佐剂。
Eur J Immunol. 2002 Oct;32(10):2857-65. doi: 10.1002/1521-4141(2002010)32:10<2857::AID-IMMU2857>3.0.CO;2-R.
7
Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.在存在麻疹病毒特异性母体抗体的情况下,单剂量免疫接种成功诱导疫苗引起的血清转化。
J Virol. 2000 May;74(10):4652-7. doi: 10.1128/jvi.74.10.4652-4657.2000.
8
Extent of measles virus spread and immune suppression differentiates between wild-type and vaccine strains in the cotton rat model (Sigmodon hispidus).在棉鼠模型(棉鼠)中,麻疹病毒的传播范围和免疫抑制在野生型和疫苗株之间存在差异。
J Virol. 2003 Jan;77(1):150-8. doi: 10.1128/jvi.77.1.150-158.2003.
9
The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity.Toll样受体配体MALP-2刺激树突状细胞成熟并调节蛋白酶体组成和活性。
Eur J Immunol. 2004 Mar;34(3):899-907. doi: 10.1002/eji.200324511.
10
Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus).在棉鼠模型(刚毛棉鼠)中,于存在母源抗体的情况下研究实验性麻疹病毒疫苗。
Vaccine. 2001 Mar 21;19(17-19):2250-3. doi: 10.1016/s0264-410x(00)00454-0.

引用本文的文献

1
Pushing the envelope: Immune mechanism and application landscape of macrophage-activating lipopeptide-2.推陈出新:巨噬细胞激活脂质肽 2 的免疫机制和应用前景。
Front Immunol. 2023 Jan 24;14:1113715. doi: 10.3389/fimmu.2023.1113715. eCollection 2023.
2
TLR-2 activation induces regulatory T cells and long-term suppression of asthma manifestations in mice.TLR-2 激活诱导调节性 T 细胞,并在小鼠中长期抑制哮喘表现。
PLoS One. 2013;8(2):e55307. doi: 10.1371/journal.pone.0055307. Epub 2013 Feb 5.
3
Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs.
TLR2 激动剂 MALP-2 和 Pam3Cys 在离体小鼠肺中的作用。
PLoS One. 2010 Nov 16;5(11):e13889. doi: 10.1371/journal.pone.0013889.
4
Beneficial effects of TLR-2/6 ligation in pulmonary bacterial infection and immunization with Pseudomonas aeruginosa.TLR-2/6 激动剂在肺部细菌感染和铜绿假单胞菌免疫中的有益作用。
Inflammation. 2010 Feb;33(1):58-64. doi: 10.1007/s10753-009-9158-7.
5
Synthetic lipopeptide MALP-2 inhibits intracellular growth of Mycobacterium bovis BCG in alveolar macrophages-preliminary data.
Inflammation. 2009 Aug;32(4):247-51. doi: 10.1007/s10753-009-9127-1.
6
TLR2/6 stimulation of the rat lung: effects on lymphocyte subsets, natural killer cells and dendritic cells in different parts of the air-conducting compartments and at different ages.大鼠肺脏的Toll样受体2/6刺激:对不同年龄段导气区不同部位淋巴细胞亚群、自然杀伤细胞和树突状细胞的影响
Immunology. 2009 Jan;126(1):132-9. doi: 10.1111/j.1365-2567.2008.02886.x. Epub 2008 Jun 19.
7
Modulation of asthma and allergy by addressing toll-like receptor 2.通过靶向 Toll 样受体 2 调节哮喘和过敏。
J Occup Med Toxicol. 2008 Feb 27;3 Suppl 1(Suppl 1):S5. doi: 10.1186/1745-6673-3-S1-S5.
8
Coincidence of different structures of mucosa-associated lymphoid tissue (MALT) in the respiratory tract of children: no indications for enhanced mucosal immunostimulation in sudden infant death syndrome (SIDS).儿童呼吸道黏膜相关淋巴组织(MALT)不同结构的巧合:婴儿猝死综合征(SIDS)中无增强黏膜免疫刺激的迹象。
Clin Exp Immunol. 2006 Oct;146(1):54-9. doi: 10.1111/j.1365-2249.2006.03190.x.